Complete Filing Data
Rectitude Holdings Ltd. reported Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents of $4.94 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Rectitude Holdings Ltd. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Selling And Marketing Expense | $4.8M | $3.4M | $2.1M | $1.7M |
| Revenues | $43.8M | $41.4M | $37.6M | $29.8M |
| Other Nonoperating Income | $421.2K | $198.4K | $156.9K | $130.5K |
| Operating Income Loss | $1.7M | $4.2M | $4.8M | $2.5M |
| Operating Expenses | $9.3M | $10.5M | $7.4M | $6.2M |
| Net Income Loss | $2.2M | $3.4M | $3.9M | $2.1M |
| Interest Expense Nonoperating | $149.2K | $214.5K | $142.5K | $119.2K |
| Income Taxes Paid Net | -$943.1K | -$660.5K | -$316.4K | -$455.7K |
| Income Tax Expense Benefit | $163.6K | $792.2K | $870.3K | $439.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $1.8M | $4.1M | $4.8M | $2.5M |
| Gross Profit | $11.0M | $14.7M | $12.1M | $8.7M |
| General And Administrative Expense | $5.6M | $7.0M | $5.2M | $4.5M |
| Cost Of Revenue | $29.1M | $26.6M | $25.5M | $21.1M |
| Amortization Of Intangible Assets | $960.8K | $986.4K | $667.7K | $553.7K |
| Research And Development Expense | $156.9K | $76.4K | $83.7K | $89.1K |
| Deferred Income Tax Liabilities Net | $1.4K | $1.4K | $1.4K | |
| Nonoperating Income Expense | $220.6K | -$16.0K | $14.4K | |
| Comprehensive Income Net Of Tax | $1.6M | $3.4M | $3.9M | |
| Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax | -$45.4K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $4.9M | $3.5M | $2.4M | $1.1M | $1.0M |
| Stockholders Equity | $24.8M | $14.6M | $11.2M | $9.5M | $9.3M |
| Gain Loss On Sale Of Property Plant Equipment | $957.00 | $5.0K | $386.00 | -$3.7K | |
| Finance Lease Principal Payments | $123.0K | $77.0K | $174.0K | $167.4K | |
| Operating Lease Modifications | $30.8K | $7.0K | $54.0K | ||
| Inventory Net | $7.6M | $6.2M | $5.8M | ||
| Taxes Payable Current | $337.7K | $1.2M | $1.0M | ||
| Retained Earnings Accumulated Deficit | $10.0M | $11.2M | $7.9M | ||
| Property Plant And Equipment Net | $4.8M | $5.8M | $6.1M | ||
| Other Receivables Net Current | $1.4M | $497.3K | $431.1K | ||
| Other Notes Payable Current | $2.2M | $3.1M | $429.6K | ||
| Operating Lease Right Of Use Asset | $3.3M | $4.5M | $2.6M | ||
| Operating Lease Liability Noncurrent | $3.4M | $3.5M | $2.0M | ||
| Operating Lease Liability Current | $1.3M | $1.2M | $670.2K | ||
| Notes Payable To Bank Noncurrent | $2.8M | $3.1M | $3.4M | ||
| Notes Payable To Bank Current | $297.5K | $598.8K | $381.1K | ||
| Liabilities Noncurrent | $6.8M | $6.9M | $5.9M | ||
| Liabilities Current | $12.1M | $12.7M | $11.6M | ||
| Liabilities And Stockholders Equity | $43.7M | $34.2M | $28.7M | ||
| Liabilities | $18.9M | $19.6M | $17.5M | ||
| Inventory Write Down | $56.4K | $256.9K | $157.3K | ||
| Finance Lease Liability Noncurrent | $441.4K | $379.5K | $494.0K | ||
| Finance Lease Liability Current | $199.3K | $168.2K | $211.1K | ||
| Common Stock Value | $1.5K | $1.7K | $1.7K | ||
| Assets Noncurrent | $16.2M | $10.6M | $8.9M | ||
| Assets Current | $27.5M | $23.6M | $19.8M | ||
| Assets | $43.7M | $34.2M | $28.7M | ||
| Accounts Receivable Net Current | $11.5M | $11.5M | $10.9M | ||
| Accounts Payable Current | $5.6M | $6.4M | $6.7M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $3.2M | $1.0M | $1.3M | ||
| Repayments Of Bank Debt | $566.8K | $126.6K | $1.1M | $390.1K | |
| Notes And Loans Receivable Net Noncurrent | $3.9M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Proceeds From Sale Of Property Plant And Equipment | $1.0K | $5.0K | $386.00 | $1.1K |
| Payments To Acquire Property Plant And Equipment | $458.0K | $235.4K | $13.6K | $189.8K |
| Net Cash Provided By Used In Operating Activities | $200.1K | $4.2M | $3.6M | $1.3M |
| Net Cash Provided By Used In Investing Activities | -$5.8M | -$230.4K | -$13.2K | -$188.7K |
| Net Cash Provided By Used In Financing Activities | $8.8M | -$2.9M | -$2.3M | -$1.0M |
| Increase Decrease In Other Receivables | $948.2K | -$35.7K | $53.4K | -$118.4K |
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | -$850.4K | $1.6M | -$234.7K | -$55.9K |
| Increase Decrease In Operating Lease Liability | -$911.1K | -$816.9K | -$636.2K | -$539.0K |
| Increase Decrease In Leasing Receivables | $39.9K | $80.5K | $41.2K | $34.9K |
| Increase Decrease In Inventories | $987.8K | $524.5K | $418.2K | $658.4K |
| Increase Decrease In Accrued Income Taxes Payable | -$537.8K | $131.7K | $553.9K | -$16.6K |
| Increase Decrease In Accounts Receivable | $397.4K | $899.6K | $1.7M | $1.8M |
| Increase Decrease In Accounts Payable | $840.8K | -$229.8K | $594.7K | $915.2K |
| Depreciation Depletion And Amortization | $609.7K | $536.0K | $540.1K | $530.9K |
| Increase Decrease In Due To Related Parties | $121.2K | $32.3K | -$196.6K | |
| Proceeds From Repayments Of Notes Payable | -$187.0K | $161.1K | $503.9K | |
| Payments Of Dividends | $2.0M | $1.2M | $950.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Earnings Per Share Diluted | $0.16 | $0.27 | $0.31 | $0.17 |
| Earnings Per Share Basic | $0.12 | $0.27 | $0.31 | $0.17 |
| Weighted Average Number Of Shares Outstanding Basic | 14.1M | 12.5M | 12.5M | 12.5M |
| Weighted Average Number Of Diluted Shares Outstanding | 14.1M | 12.5M | 12.5M | 12.5M |
| Common Stock Shares Outstanding | 14.5M | 12.5M | 12.5M | |
| Common Stock Shares Issued | 14.5M | 12.5M | 12.5M | |
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Provision For Other Credit Losses | $266.6K | $68.4K | $214.2K | $319.9K |
| Interest Paid Net | $200.6K | $214.5K | $142.5K | $119.2K |
| Fair Value Change In Financial Instrument | $4.1K | $9.5K | $1.5K | $5.8K |
| Financial Instruments | $236.8K | $231.3K | $221.8K |
Most recent annual filing with the SEC: July 31, 2025
Data sourced from SEC EDGAR public filings as of August 9, 2026.